Skip to main content
. Author manuscript; available in PMC: 2010 Sep 13.
Published in final edited form as: Arch Dermatol. 2008 Dec;144(12):1584–1592. doi: 10.1001/archdermatol.2008.517

Table 3.

Odds Ratios for Uterine Leiomyoma According to FH Germline Mutation Status and Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Clinical Status Among 105 Women

No. (%)
Variable Uterine
Fibroid
Positive
(n=77)		 Uterine
Fibroid
Negative
(n=28)		 Odds Ratio
(95% Confidence
Interval)
Germline mutation status
  FH positive 64 (83.1) 11 (39.3) 7.6 (2.9–20.0)
  FH negative 13 (16.9) 17 (60.7)
HLRCC clinical status
  Affected 54 (70.1) 6 (21.4) 8.6 (3.1–24.0)
  Unaffected 23 (29.9) 22 (78.6)
Combined FH germline
  mutation status and
  HLRCC clinical status
    FH positive and
      HLRCC unaffected		 10 (13.0) 5 (17.9) 4.5 (1.0–21.6)
    FH positive and
      HLRCC affected		 54 (70.1) 6 (21.4) 1 [Reference]
    FH negative and
      HLRCC unaffected		 13 (16.9) 17 (60.7) 11.8 (3.5–42.1)